SEC Form 4Coverage since Jun 1, 2026
$ALNY insider trading
Over the last 12 months, Alnylam Pharmaceuticals insiders reported no purchases and 5 sales totaling $1.1M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $1.1M 5 events
- Events · 12m
- 5 Form 4 filings, grouped
- Insiders · 12m
- 1 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $ALNY · 12Mvia TradingView
Top insiders · 12m
PYOTT DAVID E I—5× · $1.1M
All insider trades
5 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | PYOTT DAVID E ID | ▼ Sale | 17 | $302.65 | $5K | -1.1% | plan |
| Jun 1, 2026 | PYOTT DAVID E ID | ▼ Sale | 495 | $300.72 | $149K | -23.6% | plan |
| Jun 1, 2026 | PYOTT DAVID E ID | ▼ Sale | 1,222 | $299.87 | $366K | -36.9% | plan |
| Jun 1, 2026 | PYOTT DAVID E ID | ▼ Sale | 1,175 | $298.91 | $351K | -26.2% | plan |
| Jun 1, 2026 | PYOTT DAVID E ID | ▼ Sale | 921 | $297.71 | $274K | -17% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ALNY feed.